Flagship Pioneering, Inc.
The Preclinical Development Program Manager at Montai Therapeutics supports advancement of therapeutic programs from development candidates toward first-in-human studies within a fast-paced biotech environment. The role is a visible, strategic position that works with cross-functional teams and leadership to align program objectives with corporate goals. It sits at the intersection of preclinical and early clinical development in an AI-driven drug discovery company.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Founded
2000
Flagship Pioneering is a venture creation and investment firm that invents, builds, and funds early-stage companies in biotechnology, life sciences, and sustainability. Using an integrated model of in-house science, lab infrastructure, capital, and operational support, it spins out and scales breakthrough ventures — it has helped found more than 100 companies, including high-profile names such as Moderna. Flagship focuses on deep‑science innovation and long‑term partnerships to translate novel discoveries into transformative products for human health and the planet.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Flagship Pioneering, Inc..
individual investors who own 52% along with institutions invested in Seres Therapeutics, Inc. (NASDAQ:MCRB) saw increase in their holdings value last week
Jul 20, 2025